ARCHIVES

Also in this 8-page issue: John Niederhuber joins NCI as special advisor, quits NCAB. Harold Freeman steps down as NCI disparities head.

This article is from The Cancer Letter archive.

Vol. 31 No. 32 | September 9, 2005

Download PDF Visit The Full Archive

Related Articles

Chemotherapy Patients Can Benefit From Heart Failure Treatment, Study Finds

October 25, 2002

DCCP Board Okays Concept Of Study On Black/White Survival Differences

March 5, 1982

Concurrent Trastuzumab and Anthracyclines Not Necessary for High Pathological Response

November 29, 2013

White House Announces FDA Initiatives To accelerate Cancer Drug Approval

April 4, 1996

ICCCR Issues RFP For Cancer Risk Scale

March 6, 1992

Patients Advocates Develop Statement On Health Care Reform

March 12, 1993